Trade Summary
4 days ago, Cowan Elvia, serving as SVP, Finance, CAO at Vaxcyte, Inc. (PCVX), sold 2,500 shares at $58.59 per share, for a total transaction value of $146,482.00. Following this transaction, Cowan Elvia now holds 30,867 shares of PCVX.
This sale represents a 7.00% decrease in Cowan Elvia's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, meaning the disclosure happened on the same day as the trade.
Vaxcyte, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.